
|Articles|September 1, 2002
Combination clindamycin/benzoyl peroxide succeeds simply in moderate-to-severeacne
New Orleans - The combination product containing clindamycin 1percent with benzoyl peroxide 5 percent in an aqueous vehicle base (BenzaClin)is a highly effective and well-tolerated treatment for patients with moderateto moderately severe acne, according to the results of two randomized, controlled,double-blind studies presented at the annual meeting of the American Academyof Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
2
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
3
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
4
Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis
5














